These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9283721)

  • 1. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase.
    Stanley WC; Li B; Bonhaus DW; Johnson LG; Lee K; Porter S; Walker K; Martinez G; Eglen RM; Whiting RL; Hegde SS
    Br J Pharmacol; 1997 Aug; 121(8):1803-9. PubMed ID: 9283721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of nepicastat (RS-25560-197), a novel dopamine beta-hydroxylase inhibitor.
    Stanley WC; Lee K; Johnson LG; Whiting RL; Eglen RM; Hegde SS
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):963-70. PubMed ID: 9641484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-beta-hydroxylase inhibition: a novel sympatho-modulatory approach for the treatment of congestive heart failure.
    Hegde SS; Friday KF
    Curr Pharm Des; 1998 Dec; 4(6):469-79. PubMed ID: 10197057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.
    Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P
    Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopamine β-hydroxylase inhibitor, nepicastat, reduces different alcohol-related behaviors in rats.
    Colombo G; Maccioni P; Vargiolu D; Loi B; Lobina C; Zaru A; Carai MA; Gessa GL
    Alcohol Clin Exp Res; 2014 Sep; 38(9):2345-53. PubMed ID: 25257286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine β-hydroxylase inhibitor, nepicastat, suppresses chocolate self-administration and reinstatement of chocolate seeking in rats.
    Zaru A; Maccioni P; Colombo G; Gessa GL
    Br J Nutr; 2013 Oct; 110(8):1524-33. PubMed ID: 23561307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Sherman SS; Erickson R; DeWolf WE; Berkowitz BA
    J Pharmacol Exp Ther; 1987 May; 241(2):554-9. PubMed ID: 3572812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylase.
    Beliaev A; Learmonth DA; Soares-da-Silva P
    J Med Chem; 2006 Feb; 49(3):1191-7. PubMed ID: 16451083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex.
    Devoto P; Flore G; Saba P; Frau R; Gessa GL
    Brain Behav; 2015 Oct; 5(10):e00393. PubMed ID: 26516613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat.
    Loureiro AI; Bonifácio MJ; Fernandes-Lopes C; Pires N; Igreja B; Wright LC; Soares-da-Silva P
    Xenobiotica; 2015; 45(9):828-39. PubMed ID: 25915108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein.
    Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
    Eur J Pharm Sci; 2018 May; 117():35-40. PubMed ID: 29428540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
    J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex.
    Devoto P; Flore G; Saba P; Bini V; Gessa GL
    Addict Biol; 2014 Jul; 19(4):612-22. PubMed ID: 23289939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nepicastat upon dopamine-β-hydroxylase activity and dopamine and norepinephrine levels in the rat left ventricle, kidney, and adrenal gland.
    Catelas DN; Serrão MP; Soares-Da-Silva P
    Clin Exp Hypertens; 2020; 42(2):118-125. PubMed ID: 30821508
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
    Sabbah HN; Stanley WC; Sharov VG; Mishima T; Tanimura M; Benedict CR; Hegde S; Goldstein S
    Circulation; 2000 Oct; 102(16):1990-5. PubMed ID: 11034950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.
    Pires NM; Igreja B; Moura E; Wright LC; Serrão MP; Soares-da-Silva P
    Hypertens Res; 2015 Sep; 38(9):605-12. PubMed ID: 25854989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.
    De La Garza R; Bubar MJ; Carbone CL; Moeller FG; Newton TF; Anastasio NC; Harper TA; Ware DL; Fuller MA; Holstein GJ; Jayroe JB; Bandak SI; Reiman KZ; Neale AC; Pickford LB; Cunningham KA
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():40-48. PubMed ID: 25602710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
    Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
    Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chemical sympathectomy on the increases in plasma catecholamines and dopamine-beta-hydroxylase induced by forced immobilization and insulin-induced hypoglycemia: origin and fate of plasma dopamine-beta-hydroxylase.
    Israel AS; Barbella YR; Cubeddu LX
    J Pharmacol Exp Ther; 1982 Jun; 221(3):577-83. PubMed ID: 7045331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.